Effect of carbamazepine on tetrodotoxin-resistant Na+ channels in trigeminal ganglion neurons innervating to the dura |
Han, Jin-Eon
(Department of Pharmacology, School of Dentistry, Kyungpook National University)
Cho, Jin-Hwa (Department of Pharmacology, School of Dentistry, Kyungpook National University) Nakamura, Michiko (Department of Pharmacology, School of Dentistry, Kyungpook National University) Lee, Maan-Gee (Brain Science & Engineering Institute, Kyungpook National University) Jang, Il-Sung (Department of Pharmacology, School of Dentistry, Kyungpook National University) |
1 | Shank RP, Gardocki JF, Streeter AJ, Maryanoff BE. An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action. Epilepsia. 2000;41 Suppl 1:S3-9. |
2 | Schmidt D, Elger CE. What is the evidence that oxcarbazepine and carbamazepine are distinctly different antiepileptic drugs? Epilepsy Behav. 2004;5:627-635. DOI |
3 |
Dailey JW, Reith ME, Yan QS, Li MY, Jobe PC. Carbamazepine increases extracellular serotonin concentration: lack of antagonism by tetrodotoxin or zero |
4 | Dailey JW, Reith ME, Steidley KR, Milbrandt JC, Jobe PC. Carbamazepine- induced release of serotonin from rat hippocampus in vitro. Epilepsia. 1998;39:1054-1063. DOI |
5 |
Kawata Y, Okada M, Murakami T, Kamata A, Zhu G, Kaneko S. Pharmacological discrimination between effects of carbamazepine on hippocampal basal, |
6 | Tatsumi M, Groshan K, Blakely RD, Richelson E. Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol. 1997;340:249-258. DOI |
7 | Xu XM, Yang C, Liu Y, Dong MX, Zou DZ, Wei YD. Efficacy and feasibility of antidepressants for the prevention of migraine in adults: a meta-analysis. Eur J Neurol. 2017;24:1022-1031. DOI |
8 | Silberstein SD. Migraine pathophysiology and its clinical implications. Cephalalgia. 2004;24 Suppl 2:2-7. |
9 | Benemei S, Nicoletti P, Capone JG, Geppetti P. CGRP receptors in the control of pain and inflammation. Curr Opin Pharmacol. 2009;9:9-14. DOI |
10 | Bolay H, Reuter U, Dunn AK, Huang Z, Boas DA, Moskowitz MA. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med. 2002;8:136-142. DOI |
11 | Gold MS, Reichling DB, Shuster MJ, Levine JD. Hyperalgesic agents increase a tetrodotoxin-resistant Na+ current in nociceptors. Proc Natl Acad Sci USA. 1996;93:1108-1112. DOI |
12 | Gold MS, Levine JD, Correa AM. Modulation of TTX-R INa by PKC and PKA and their role in PGE2-induced sensitization of rat sensory neurons in vitro. J Neurosci. 1998;18:10345-10355. DOI |
13 | Nakamura M, Jang IS. Characterization of dural afferent neurons innervating cranial blood vessels within the dura in rats. Brain Res. 2018;1696:91-102. DOI |
14 | Schneider H, Stenzel E. [Carbamazepine--daily course in the serum during long term medication]. Bibl Psychiatr. 1975;(151):32-42. |
15 | Bertilsson L. Clinical pharmacokinetics of carbamazepine. Clin Pharmacokinet. 1978;3:128-143. DOI |
16 | Taverna S, Mantegazza M, Franceschetti S, Avanzini G. Valproate selectively reduces the persistent fraction of Na+ current in neocortical neurons. Epilepsy Res. 1998;32:304-308. DOI |
17 | Taverna S, Sancini G, Mantegazza M, Franceschetti S, Avanzini G. Inhibition of transient and persistent Na+ current fractions by the new anticonvulsant topiramate. J Pharmacol Exp Ther. 1999;288:960-968. |
18 | Stafstrom CE. Persistent sodium current and its role in epilepsy. Epilepsy Curr. 2007;7:15-22. DOI |
19 | Hains BC, Waxman SG. Sodium channel expression and the molecular pathophysiology of pain after SCI. Prog Brain Res. 2007;161:195-203. |
20 | Hur YK, Choi IS, Cho JH, Park EJ, Choi JK, Choi BJ, Jang IS. Effects of carbamazepine and amitriptyline on tetrodotoxinresistant Na+ channels in immature rat trigeminal ganglion neurons. Arch Pharm Res. 2008;31:178-182. DOI |
21 | Goadsby PJ. Recent advances in understanding migraine mechanisms, molecules and therapeutics. Trends Mol Med. 2007;13:39-44. DOI |
22 | Diener HC, Dodick DW, Goadsby PJ, Lipton RB, Olesen J, Silberstein SD. Chronic migraine--classification, characteristics and treatment. Nat Rev Neurol. 2012;8:162-171. DOI |
23 | Ferrari MD. The economic burden of migraine to society. Pharmacoeconomics. 1998;13:667-676. DOI |
24 | Michel P, Dartigues JF, Lindoulsi A, Henry P. Loss of productivity and quality of life in migraine sufferers among French workers: results from the GAZEL cohort. Headache. 1997;37:71-78. DOI |
25 | Evers S, Afra J, Frese A, Goadsby PJ, Linde M, May A, Sandor PS. EFNS guideline on the drug treatment of migraine--revised report of an EFNS task force. Eur J Neurol. 2009;16:968-981. DOI |
26 | Malik SN, Hopkins M, Young WB, Silberstein SD. Acute migraine treatment: patterns of use and satisfaction in a clinical population. Headache. 2006;46:773-780. DOI |
27 | Silberstein SD, Marmura MJ. Acute migraine treatment. Headache. 2015;55:1-2. |
28 | Silberstein SD, Goadsby PJ. Migraine: preventive treatment. Cephalalgia. 2002;22:491-512. DOI |
29 | Silberstein SD. Preventive treatment of migraine. Trends Pharmacol Sci. 2006;27:410-415. DOI |
30 | Sidhu HS, Sadhotra A. Current status of the new antiepileptic drugs in chronic pain. Front Pharmacol. 2016;7:276. |
31 | Bennett BD, Callaway JC, Wilson CJ. Intrinsic membrane properties underlying spontaneous tonic firing in neostriatal cholinergic interneurons. J Neurosci. 2000;20:8493-8503. DOI |
32 | Willow M, Gonoi T, Catteral W. Voltage clamp analysis of the inhibitory actions of diphenyihydantoin and carbamazepine on voltagesensitive sodium channels in neuroblastoma cells. J Mol Pharmacol. 1985;27:549-558. |
33 | Singh JN, Jain G, Ramarao P, Sharma SS. Inhibition of sodium current by carbamazepine in dorsal root ganglion neurons in vitro. Indian J Physiol Pharmacol. 2009;53:147-154. |
34 | Crill WE. Persistent sodium current in mammalian central neurons. Annu Rev Physiol. 1996;58:349-362. DOI |
35 | Taddese A, Bean BP. Subthreshold sodium current from rapidly inactivating sodium channels drives spontaneous firing of tuberomammillary neurons. Neuron. 2002;33:587-600. DOI |
36 | Jackson AC, Yao GL, Bean BP. Mechanism of spontaneous firing in dorsomedial suprachiasmatic nucleus neurons. J Neurosci. 2004;24:7985-7998. DOI |
37 | Pape HC. Queer current and pacemaker: the hyperpolarizationactivated cation current in neurons. Annu Rev Physiol. 1996;58:299-327. DOI |
38 | Linde M, Mulleners WM, Chronicle EP, McCrory DC. Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults. Cochrane Database Syst Rev. 2013;6:CD010611. |
39 | Rogawski M. Common pathophysiologic mechanisms in migraine and epilepsy. Arch Neurol. 2008;65:709-714. |
40 | Linde M, Mulleners WM, Chronicle EP, McCrory DC. Topiramate for the prophylaxis of episodic migraine in adults. Cochrane Database Syst Rev. 2013;6:CD010610. |
41 | Rompel H, Bauermeister PW. Aetiology of migraine and prevention with carbamazepine (Tegretol): results of a double-blind, cross-over study. S Afr Med J. 1970;44:75-80. |
42 | Tanelian DL, Brose WG. Neuropathic pain can be relieved by drugs that are use-dependent sodium channel blockers: lidocaine, carbamazepine, and mexiletine. Anesthesiology. 1991;74:949-951. DOI |
43 | Steiner TJ, Findley LJ, Yuen AW. Lamotrigine versus placebo in the prophylaxis of migraine with and without aura. Cephalalgia. 1997;17:109-112. DOI |
44 | Silberstein S, Saper J, Berenson F, Somogyi M, McCague K, D'Souza J. Oxcarbazepine in migraine headache: a double-blind, randomized, placebo-controlled study. Neurology. 2008;70:548-555. DOI |
45 | Gupta P, Singh S, Goyal V, Shukla G, Behari M. Low-dose topiramate versus lamotrigine in migraine prophylaxis (the Lotolamp study). Headache. 2007;47:402-412. |
46 | Baker KA, Taylor JW, Lilly GE. Treatment of trigeminal neuralgia: use of baclofen in combination with carbamazepine. Clin Pharm. 1985;4:93-96. |
47 | Sidebottom A, Maxwell S. The medical and surgical management of trigeminal neuralgia. J Clin Pharm Ther. 1995;20:31-35. DOI |
48 | Backonja MM. Use of anticonvulsants for treatment of neuropathic pain. Neurology. 2002;59(5 Suppl 2):S14-17. DOI |
49 | Harriott AM, Gold MS. Electrophysiological properties of dural afferents in the absence and presence of inflammatory mediators. J Neurophysiol. 2009;101:3126-3134. DOI |
50 | Brau ME, Dreimann M, Olschewski A, Vogel W, Hempelmann G. Effect of drugs used for neuropathic pain management on tetrodotoxin-resistant Na+ currents in rat sensory neurons. Anesthesiology. 2001;94:137-144. DOI |
51 | Murase K, Ryu PD, Randic M. Excitatory and inhibitory amino acids and peptide-induced responses in acutely isolated rat spinal dorsal horn neurons. Neurosci Lett. 1989;103:56-63. DOI |
52 | Drake ME Jr, Greathouse NI, Renner JB, Armentbright AD. Openlabel zonisamide for refractory migraine. Clin Neuropharmacol. 2004;27:278-280. DOI |
53 | Galletti F, Cupini LM, Corbelli I, Calabresi P, Sarchielli P. Pathophysiological basis of migraine prophylaxis. Prog Neurobiol. 2009;89:176-192. DOI |
54 | Chiossi L, Negro A, Capi M, Lionetto L, Martelletti P. Sodium channel antagonists for the treatment of migraine. Expert Opin Pharmacother. 2014;15:1697-1706. DOI |
55 | Lampl C, Katsarava Z, Diener HC, Limmroth V. Lamotrigine reduces migraine aura and migraine attacks in patients with migraine with aura. J Neurol Neurosurg Psychiatry. 2005;76:1730-1732. DOI |
56 | Mohammadianinejad SE, Abbasi V, Sajedi SA, Majdinasab N, Abdollahi F, Hajmanouchehri R, Faraji A. Zonisamide versus topiramate in migraine prophylaxis: a double-blind randomized clinical trial. Clin Neuropharmacol. 2011;34:174-177. DOI |
57 | Rush AM, Elliott JR. Phenytoin and carbamazepine: differential inhibition of sodium currents in small cells from adult rat dorsal root ganglia. Neurosci Lett. 1997;226:95-98. DOI |
58 | Johannessen CU. Mechanisms of action of valproate: a commentatory. Neurochem Int. 2000;37:103-110. DOI |
![]() |